Medtech 52 North Health has been awarded $1.4m (£1.1m) in funding from SBRI Healthcare.
Cambridge-headquartered 52 North Health will use the capital to develop its NeutroCheck device and transfer to manufacturing and clinical usability trials.
Founded in 2018, 52 North Health aims to improve healthcare by introducing fully-integrated, AI and medical-device systems. Its platform allows for both soluble and insoluble biomarkers to be found from a single biological specimen using an app supported device the NeutroCheck.
NeutroCheck is a device for patients on chemotherapy who are at risk of neutropenic sepsis. The portable device lets at home patients determine their risk, through a blood finger-prick.
“We are privileged to have the support of the SBRI Healthcare programme and are committed to working with our world-leading collaborators to deliver on our ambitions to improve the care of cancer patients,” says Dr Saif Ahmad, co-founder, 52 North Health
According to 52 North Health, Neutropenic sepsis kills three people in England and Wales every day.
Currently, patients going through chemotherapy who feel unwell are told to go to A&E, where patients are given antibiotics and blood tests, however, half are found to have no risk.
The Medtech will partner with Macmillan Cancer Support and the UK Sepsis Trust.
“Neutropenic sepsis is a life-threatening condition and managing the risks can be very stressful for people with cancer, who are already dealing with all the challenges that a diagnosis can bring,” said Tanya Humphreys, head of innovation partnerships, Macmillan Cancer Support.
SBRI Healthcare is funded by NHS England and helped by the Academic Health Science Network.
SBRI Healthcare’s investment follows previous funding in January 2021 for £100,000.
“Good care is a lifeline, not a luxury, and giving patients the tools to better manage their care can be a key component to helping to improve their quality of life,” added Humphreys.
SBRI Healthcare earlier this year spent £9m on eight late-stage projects developing cancer diagnosis technologies.
The post Medtech 52 North Health awarded £1m for cancer treatment device appeared first on UKTN | UK Tech News.